Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO22305-T1

Polycystic kidney disease Therapy Area:

Method Type of patent:

Use of inhibitors of the hippo signalling pathway for the treatment of

Chronic nephropathies represent a real global public health concern. In particular, nephronophthisis (NPH) is an orphan genetic disease affecting the […]

BIO24124-T1

Polycystic kidney disease Therapy Area:

Method Type of patent:

Methods and pharmaceutical composition for treating ciliopathies

Inventors have found that CB1 inhibition (genetic invalidation or using a pharmacological peripheral blockade) reduces CKD and fibrosis in the severe […]

BIO18528-T1

Polycystic kidney disease Therapy Area:

Method Type of patent:

Methods and pharmaceutical compositions for the treatment of autosomal

Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disease affecting 1 in 1,000 to 1 in 2,500 individuals worldwide. The […]

147

56

310

46

Our Technology Offers

Use of inhibitors of the hippo signalling pathway for the treatment of

Methods and pharmaceutical composition for treating ciliopathies

Methods and pharmaceutical compositions for the treatment of autosomal

You might also be interested in

Mucosal-associated invariant t (mait) cells

Methods of treatment of iron overload associated

Methods of treating iron deficiency-related

Gpr50 ligands for use for treating diseases

Chronopharmacoligical use of dhodh inhibitor for

Use of retinoic acid receptor (rar) agonists

Methods for the treatment of endometriosis

Use of tryptophan hydroxylase 1 (tph1) inhibitors

Use of cd9 as a biomarker and as a biotarget in

Use of inhibitors of the hippo signalling pathway

Bacteroides faecichinchilleae and its use in the

Use of shp2 inhibitors for inhibiting senescence